A British man who rejected the standard of care to treat his brain cancer has lived with the typically fatal glioblastoma tumor growing very slowly after adopting a ketogenic diet, providing a case study that researchers ...
Jun 10, 2021
0
1519
Scripps Research scientists have discovered a compound that potently and selectively kills the stem-like cells that make glioblastoma brain cancers so deadly.
Mar 8, 2019
0
1518
Glioblastoma (GBM), an aggressive brain cancer, is notoriously resistant to treatment, with recurrent GBM associated with survival of less than 10 months. Immunotherapies, which mobilize the body's immune defenses against ...
Oct 18, 2023
0
344
Findings from a seven-year research project suggests that there could be a new approach to treating one of the most common and devasting forms of brain cancer in adults—Glioblastoma Multiforme (GBM).
May 9, 2022
0
105
A combination of immunotherapy agents that encourages some immune cells to eat cancer cells and alert others to attack tumors put mice with a deadly type of brain cancer called glioblastoma into long-term remission, a new ...
Apr 24, 2020
0
201
A team of researchers from Yale University and Yale School of Medicine has developed a temozolomide analog for use as a chemotherapy drug in treating glioma. In their paper published in the journal Science, the researchers ...
One of the deadliest forms of cancer is the brain tumor glioblastoma multiforme (GBM). It is a rare disease, with approximately 28,000 cases diagnosed every year in the EU and the US, for which median survival does not exceed ...
Aug 22, 2022
0
39
City of Hope scientists have developed and tested the first chimeric antigen receptor (CAR) T cell therapy using chlorotoxin (CLTX), a component of scorpion venom, to direct T cells to target brain tumor cells, according ...
Mar 4, 2020
0
46
The deadly brain cancer glioblastoma (GBM) is often resistant to chemotherapy and radiation, but new research from the Perelman School of Medicine at the University of Pennsylvania and Penn's Abramson Cancer Center shows ...
Feb 26, 2020
0
87
Multi-institutional researchers have succeeded in efficiently delivering an immune checkpoint inhibitor (ICI) into the mouse brain, confirming its high efficacy and specificity in treating orthotopically transplanted mice ...
Oct 11, 2021
0
27
